Protein kinases and multidrug resistance

Cytotechnology

Volumn 27, Issue 1-3, 1998, Pages 203-224

  Rumsby, Martin G ^a   Drew, Lisa ^a   Roger Warr, J ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Inhibitors; Multidrug resistance; Other kinases; Phorbol esters; Phosphorylation; Protein kinase A; Protein kinase C

Indexed keywords

CANCER CELL; CYCLIC AMP DEPENDENT PROTEIN KINASE; ENZYME ACTIVITY; GLYCOPROTEIN P; IMMUNOPRECIPITATION; MULTIDRUG RESISTANCE; PHENOTYPE; PHORBOL ESTER; PROTEIN KINASE; PROTEIN KINASE C; PROTEIN PHOSPHORYLATION;

EID: 0032412212     PISSN: 09209069     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-94-017-2374-9_13     Document Type: Article

References (169)

1. Abraham I, Chin KV, Gottesman, MM, Mayo JK and Sampson KE (1990) Transfection of a mutant regulatory subunit gene of cAMP-dependent protein kinase causes increased drug sensitivity and decreased expression of Pgp. Exp Cell Res 189: 133-141.
2. Aftab DT, Yang JM and Hait WN (1994) Functional role of phosphorylation of the multidrug transporter (P-glycoprotein) by protein kinase C in multidrug-resistant MCF-7 cells. Oncol Res 6: 59-70.
3. Ahmad S, Trepel JB, Ohno S, Suzuki K, Tsuruo T and Glazer RI (1992) Role of protein kinase C in the modulation of multidrug resistance: expression of the atypical y isoform of protein kinase C does not confer increased resistance to doxorubicin. Molecular Pharmacol 42: 1004-1009.
4. Ahmad S, Safa AA and Glazer RI (1994) Modulation of Pglycoprotein by protein kinase C-α in a baculovirus expression system. Biochemistry 33: 10313-10318.
5. Ahn CH, Kong JY, Choi WC and Hwang MS (1996) Selective inhibition of the effects of phorbol ester on doxorubicin resistance and P-glycoprotein by the protein kinase inhibitor H-7 in multidrug-resistant MCF-7/Dox human breast carcinoma cells. Biochem Pharmacol 52: 393-399.
6. Aquino A, Warren BS, Omichiniski J, Hartman KD and Glazer RI (1990) Protein kinase C-γ is present in Adriamycin resistant HL-60 leukemia cells. Biochem Biophys Res Comm 166: 723-728.
7. Basu A (1993) The potential of protein kinase C as a target for anticancer treatment. Pharmac Ther 59: 257-280.
8. Bates SE, Currier SJ, Alvarez M and Fojo AT (1992) Modulation of P-glycoprotein phosphorylation and drug transport by sodium butyrate. Biochemistry 31: 6366-6372.
9. Bates SE, Lee JS, Dickstein B, Spolyar, M and Fojo, AT (1993) Differentiual modulation of P-glycoprotein transport by protein kinase inhibition. Biochemistry 32: 9156-9164.
10. Bellamy WT (1996) P-glycoproteins and multidrug resistance. Annu Rev Pharmacol Toxicol 36: 161-183.
11. Beitran PJ, Fan D, Fidler U and O'Brian CA (1997) Chemosensitization of cancer cells by the staurosporine derivative CGP41251 in association with decreased P-glycoprotein phosphorylation. Biochem Pharmacol 53: 245-247.
12. Bertram J, Palfner K, Hiddemann W and Kneba M (1996) Increase of P-glycoprotein-mediated drug resistance by hsp90β. Anti-Cancer Drugs 7: 838-845.
13. Blobe GC, Sachs CW, Khan WA, Fabbro D, Stabel S, Wetsel WC, Obeid LM, Fine RL and Hannun YA (1993) Selective regulation of expression of protein kinase C isoenzymes in multidrug-resistant MCF-7 cells. J Biol Chem 268: 658-664.
14. Bosch I and Croop J (1996) P-glycoprotein, multidrug resistance and cancer. Biochim Biophys Acta 1288: F37-F54.
15. Buchner K (1995) Protein kinase C in the transduction of signals toward and within the nucleus. Eur J Biochem 228: 211-221.
16. Budillon A, Clair T, Scala S, Bates S and Cho-Chung YS (1992) Role of type 1 regulatory subunit (RI) of cAMP-dependent protein kinase (PKA) in multidrug resistance (mdr) of cancer cells. Proc Am Assoc Cancer Res 33: 475.
17. Budworth J, Davies R, Malkhandi J, Gant TW, Ferry DR and Gescher A (1996) Comparison of staurosporine and four analogues: their effects on growth, rhodamine 123 retention and binding to P-glycoprotein in multidrug-resistant MCF-7/Adr cells. Brit J Cancer 73: 1063-1068.
18. Budworth J, Gant TW and Gescher A (1997) Co-ordinate loss of protein kinase C and multidrug resistance gene expression in revertant MCF-7/Adr breast carcinoma cells. Brit J Cancer 75: 1330-1335.
19. Buschman E and Gros P (1991) Functional analysis of chimeric genes obtained by exchanging homologous domains of the mouse MDR1 and MDR2 genes. Mol Cell Biol 11: 595-603.
20. Chambers TC, McAvoy EM, Jacobs JW and Eilon G (1990a) Protein kinase C phosphorylates P-glycoprotein in multidrugresistant human KB carcinoma cells. J Biol Chem 265: 7679-7686.
21. Chambers TC, Chalikonda I and Eilon G (1990b) Correlation of protein kinase C translocation, P-glycoprotein phosphorylation and reduced drug accumulation in multidrug-resistant human KB cells. Biochem Biophys Res Commun 169: 253-259.
22. Chambers TC, Zheng B and Kuo JF (1992) Regulation by phorbol ester and protein kinase C inhibitors and by a protein phosphatase inhibitor (okadaic acid) of P-glycoprotein phosphorylation and relationship to drug accumulation in multidrug-resistant human KB cells. Molec Pharmacol 41: 1008-1015.
23. Chambers TC, Pohl J, Raynor RL and Kuo JF (1993) Identification of specific sites in human P-glycoprotein phosphorylated by protein kinase C. J Biol Chem 268: 4592-4595.
24. Chambers TC, Pohl J, Glass DB and Kuo JF (1994) Phosphorylation by protein kinase C and cyclic AMP-dependent protein kinase of synthetic peptides derived from the linker region of human P-glycoprotein. Biochem J 299: 309-315.
25. Chambers TC (1995) expression and subcellular distribution of protein kinase C isoforms in multidrug-resistant cells. Proc Am Assoc Cancer Res 36: 2013.
26. Chaudhary PM and Roninson IB (1992) Activation of MDR1 (P-glycoprotein) gene expression in human cells by protein kinase C agonists. Oncol Res 4: 281-290.
27. Chin KV, Tanaka S, Darlington G, Pastan I and Gottesman MM (1990) Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells. J Biol Chem 265: 221-226.
28. Chin KV, Chauhan SS, Abraham I, Sampson KE, Krolczyk AJ, Wong M, Schimmer B, Pastan I and Gottesman MM (1992) reduced mRNA levels for the multidrug-resistance genes in cAMP-dependent protein kinase mutant cell lines. J Cell Phys 152: 87-94.
29. Choi WC, Kong JY and Ahn CH (1993) Mechanism of phorbol ester-induced potentiation of doxorubicin resistance in human breast cancer MCF-7/Dox cells. Proc Am Assoc Cancer Res 34: 311.
30. Cloud-Heflin BA, McMasters RA, Osborn MT and Chambers TC (1996) Expression, subcellular distribution and response to phorbol esters of protein kinase C isozymes in drug-sensitive and multidrug resistant KB cells: evidence for altered regulation of PKC-α. Eur J Biochem 239: 796-804.
31. Dang PM-C, Hakim J and Perianin (1994) Immunochemical identification and translocation of protein kinase C zeta in human neutrophils. FEES Letts 349: 338-342.
32. Davies R, Budworth J, Riley J, Snowden R, Gescher A and Gant TW (1996) Regulation of P-glycoprotein 1 and 2 gene expression and protein activity in two MCF-7/Dox cell line subclones. Brit J Cancer 73: 307-315.
33. Dekker L and Parker PJ (1994) Protein kinase C-a question of specificity. Trends Biochem Sci 19: 73-77.
34. Dekker L, Palmer RH and Parker PJ (1995) The protein kinase C and protein kinase C-related gene families. Curr Op Struc. Biol 5: 396-402.
35. Dickstein B, Valverius EM, Wosikowski K, Saceda M, Pearson JW, Martin MB and Bates SE (1993) Increased epidermal growth factor receptor in an oestrogen-responsive, Adriamycin-resistant MCF-7 cell line. J Cell Physiol 157: 110-118.
36. Doige CA, Yu X and Sharom FJ (1993) The effects of lipids and detergents on ATPase active P-glycoprotein. Biochim Biophys Acta 1146: 65-72.
37. Dolci ED, Abramson R, Xuan Y Siegfried J, Yuenger KA, Yassa DS and Tritton TR (1993) Anomalous expression of P-glycoprotein in highly drug-resistant human KB cells. Int J Cancer 54: 302-308.
38. Dolfini E, Dasdia T, Perletti G, Romagnoni M and Piccinini F (1993) Analysis of calcium-dependent protein kinase C isoenzymes in intrinsically-resistant cloned lines of LoVo cells: reversal of resistance by kinase inhibitor 1-(5-Isoquinolinylsulfonyl) 2-methylpiperazine. Anticancer Res 13: 1123-1128.
39. Dolfini E, Dasdia, T, Arancia G, Molinare A, Calcabrini A, Scheper RJ, Flens MJ, Gariboldi MB and Monti E (1997) Characterisation of a clonal human colon adenocarcinoma line intrinsically resistant to doxorubicin. Brit J Cancer 76: 67-76.
40. Dong Z, Ward NE, Fan D, Gupta, KP and O'Brian CA (1991) In vitro model for intrinsic drug resistance: effects of protein kinase C activators on the chemosensitivity of cultured human colon cancer cells. Mol Pharmacol 39: 563-569.
41. Drew, L (1996) D.Phil, thesis, University of York, England.
42. Drew L, Groome N, Hallam TJ, Warr JR and Rumsby MG (1994) Changes in protein kinase C subspecies protein expression and activity in a series of multidrug resistant human KB carcinoma cell lines. Oncol Res 6: 429-438.
43. Drew L, Groome N, Warr JR and Rumsby MG (1996) Reduced daunomycin accumulation in drug-sensitive and multidrug-resistant human carcinoma KB cells following phorbol ester treatment: a potential role for protein kinase C in reducing drug influx. Oncol Res 8: 249-257.
44. Elias L and Davis A (1985) Manganese-phospholipid stimulated protein kinase activity of human leukemic cells. J Biol Chem 260: 7023-7028.
45. Epand RM and Stafford AR (1993) Protein kinases and multidrug resistance. The Cancer Journal 6: 154-157.
46. Exton JH (1997) Phospholipase D: enzymology, mechanisms of regulation and function. Physiol Rev 77: 303-319.
47. I confers a multidrug-resistant phenotype on rat fibroblasts. Anticancer Res 12: 661-668.
48. Fenton JAL (1996) DPhil. thesis, University of York.
49. Ferguson PJ and Cheng YC (1987) Transient protection of cultured human cells against antitumour agents by 12-0-tetradecanoylphorbol-13-acetate. Cancer Res 47: 433-441.
50. Fine RL, Patel RL and Chabner BA (1988) Phorbol esters induce multidrug resistance in human breast cancer cells. Proc Natl Acad Sci USA 85: 582-586.
51. Fine RL, Chambers TC and Sachs CW (1996) P-glycoprotein, multidrug resistance and protein kinase C. Stem Cells 14: 47-55.
52. Gekeler V, Boer R, Ise W, sanders KH, Schachtele C and Beck J (1995) The specific bisindoylmaleimide PKC-inhibitor GF 109203X efficiently modulates MRP-associated multiple drug resistance. Biochem Biophys Res Commun 206: 119-126.
53. Germann UA, Chambers TC, Ambudkar SV, Pastan I and Gottesman MM (1995) Effects of phosphorylation of P-glycoprotein on multidrug resistance. J Bioenerg Biomemb 27: 53-61.
54. Germann UA, Chambers TC, Ambudkar SV, Licht T, Cardarelli CO, Pastan I and Gottesman MM (1996) Characterisation of phosphorylation-defective mutants of human P-glycoprotein expressed in mammalian cells. J Biol Chem 271: 1708-1716.
55. Glavy JS, Horwitz SB and Orr GA (1997) Identification of the in vivo phosphorylation sites for acidic-directed kinases in murine mdr 1b P-glycoprotein. J Biol Chem 272: 5909-5914.
56. Glazer RI (1994) Protein kinase C in multidrug resistance, neoplastic transformation and differentiation, In Kuo JF (ed) Protein Kinase C. (pp. 171-198) Oxford University Press, New York.
57. I isozyme. Int J Oncol 5: 1227-1231.
58. Gollapudi S, Singh H and Gupta S (1994b) Effect of 12-deoxyphorbol 13-phenylacetate on daunorubicin resistance and calcium-independent protein kinase C isozymes in drug sensitive murine leukemia P388 cells. Int J Oncol 4: 849-851.
59. Gollapudi S, Soni V, Thadepalli H and Gupta S (1995) Role of protein kinase β isozyme in multidrug-resistant P388/ADR cells. J Chemotherapy 7: 157-159.
60. Goode NT, Hajibagheri MAN and Parker PJ (1995) Protein kinase C (PKC) - induced PKC downregulation - association with upregulation of vesicle traffic. J Biol Chem 270: 2669-2675.
61. Goodfellow HR, Sardini A, Ruetz S, Calahan R, Gros P, McNaughton PA and Higgins CF (1996) Protein kinase C-mediated phosphorylation does not regulate drug transport by the human multidrug resistance P-glycoprotein. J Biol Chem 271: 13668-13674.
62. Gordge PC and Ryves WJ (1994) Inhibitors of protein kinase C. Cell Signalling 6: 871-882.
63. Gottesman MM, Pastan I and Ambudkar SV (1996) P-glycoprotein and multidrug-resistance. Curr Op Gen Dev 6: 610-617.
64. Grant S and Jarvis WD (1996) Modulation of drug-induced apoptosis by interruption of the protein kinase C signal tranduction pathway - a new therapeutic strategy. Clin Cancer Res 2: 1915-1920.
65. Grunicke H, Hofman J, Utz I and Uberall F (1994) Role of protein kinases in antitumour drug resistance. Ann Hematol 69, S1-S6.
66. Gupta S, Kim C, Qin Y and Gollapudi S (1994a) Expression of protein kinase C isoenzymes in multidrug-resistant murine leukemia P388/ADR cells. Int J Oncol 4:311-315.
67. Gupta S, Patel K, Singh H and Gollapudi S (1994b) Effect of calphostin C on daunorubicin resistance in P388/ADR and HL-60/ADR cells: reversal of drug resistance possibly via P-glycoprotein. Cancer Letts 76: 139-145.
68. Gupta KP, Ward NE, Gravitt KR, Bergman PJ and O'Brian CA (1996) Partial reversal of multidrug resistance in human breast cancer cells by an N-myristoylated protein kinase C-alpha pseudosubstrate peptide. J Biol Chem 271: 2102-2111.
69. Hait WN, Yang JM and Aftab D (1993) Effect of activation of protein kinase C on Vinca alkaloid transport in multidrug-resistant cells. Proc Am Assoc Cancer Res 34: 1882.
70. Hamada H, Hagiwara KI, Nakajima T and Tsuruo T (1987) Phosphorylation of the Mr 170,000 to 180,000 glycoprotein specific to multidrug-resistant tumour cells: effects of verapamil, trifluoperazine and phorbol esters. Cancer Res: 47: 2860-2865.
71. Hannun YA (1994) The sphingomyelin cycle and the second messenger function of ceramide. J Biol Chem 269: 3125-3128.
72. Hannun YA and Obeid LM (1995) Ceramide: an intracellular signal for apoptosis. Trends Biochem Sci 20: 73-77.
73. Heck MMS, Hittleman WN and Earnshaw WC (1989) In vivo phosphorylation of the 170 kDa form of eukaryotic DNA topoisomerase II. J Biol Chem 264: 15161-15164.
74. Hofmann J (1997) The potential for isoenzyme-selective modulation of protein kinase C. FASEB J 11: 649-669.
75. Hu YP and Robert J (1997) Inhibition of protein kinase C in multidrug-resistant cells by modulators of multidrug resistance. J Cancer Res Clin Oncol 123: 201-210.
76. Hug H and Sarre F (1993) Protein kinase C isoenzymes; divergence in signal transduction? Biochem J 291: 329-343.
77. Ido M, Asao T, Sakurai M, Inagaki M, Saito M and Hidaka H (1986) An inhibitor of protein kinase C, H-7, inhibits TPA-induced reduction of vincristine uptake from P388 murine leukemic cells. Leukemia Res 10: 1063-1069.
78. Ido M, Sata M, Sakurai M, Inagaki M, Saitoh M, Watnabe M and Hidaka H (1987) Decreased phorbol ester receptor and protein kinase C in P388 murine leukemic cells resistant to etoposide. Cancer Res 47: 3460-3463.
79. Kawada M and Umezawa K (1995) Inostamycin, an inhibitor of P-glycoprotein function, interacts specifically with phosphatidylethanolamine. Jap J Cancer Res 86: 873-878.
80. Kessel D (1988) Effect of phorbol esters on doxorubicin transport systems. Biochem Pharmacol 37: 2287-2299.
81. Kiley SC, Jaken S, Whelan R and Parker PJ (1995) Intracellular targeting of protein kinase C isoenzymes: functional implications. Biochem Soc Trans 23: 601-605.
82. Killion JJ, Beltran P, O'Brian CA, Yoon SS, Fan D, Wilson MR and Fidler IJ (1995) The antitumour activity of doxorubicin against drug-resistant murine carcinoma is enhanced by oral administration of a synthetic staurosporine analogue CGP 41251. Oncol Res 7: 453-459.
83. Kim SH, Park JH, Chung BS, Kang CD and Hidaka H (1993) Inhibition of MDR1 gene expression by H-87, a selective inhibitor of cAMP-dependent protein kinase. Cancer Letts 74: 37-41.
84. Kim SH, Lee SH, Kwak NH, Kang CD and Chung BS (1996) Effect of the activated Raf protein kinase on the human multidrug resistance l (MDR1) gene promoter. Cancer Lett 98: 199-205.
85. Kiss Z, Tomono M and Anderson WB (1994) Phorbol ester selectively stimulates the phospholipase D-mediated hydrolysis of phosphatidylethanolamine in multidrug-resistant MCF-7 human breast carcinoma cells. Biochem J 302: 649-654.
86. Kiss Z (1996) Regulation of phospholipase D by protein kinase C. Chem Phys Lipids 80: 81-102.
87. Klauck TM, Faux MC, Labudda K, Langeberg LK, Jaken S and Scott JD (1996) Coordination of three signaling enzymes by AKAP79, a mammalian scaffold protein. Science 271: 1589-1592.
88. Kuo JF (1994) Protein kinase C. Oxford Univ. Press, New York.
89. Lavie Y, Cao H, Bursten SL, Giuliano AE and cabot MC (1996) Accumulation of glucosylceramides in multidrug-resistant cancer cells. J Biol Chem 271: 19530-19536.
90. Lavie Y Cao H, Volner A, Lucci A, Han TY, Geffen V, Giuliano AE and Cabot MC (1997) Agents that reverse multidrug resistance, tamoxifen, verapamil and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells. J Biol Chem 272: 1682-1687.
91. Lee AA, Karaszkiewicz JW and Anderson WB (1992) Elevated level of protein kinase C in multidrug-resistant MCF-7 human breast carcinoma cells. Cancer Res 52: 3750-3759.
92. Lee H-W, Smith L, Pettit GR, Vinitsky A and Smith JB (1996) Ubiquitinylation of protein kinase C-α and degradation by the proteasome. J Biol Chem 271: 20973-20976.
93. Lee H-W, Smith L, Pettit GR and Smith JB (1997) Bryostatin 1 and phorbol ester down-modulate protein kinase C-α and -∈ via the ubiquitin/proteasome pathway in human fibroblasts. Mol Pharmacol 51:439-447.
94. Lee JY, Hannun YA and Obeid LM (1996) Ceramide inactivates cellular PKC-α. J Biol Chem 271: 13169-13174.
95. Lelong IH, Cardarelli CO, Gottesman MM and Pastan I (1994) GTP-stimulated phosphorylation of P-glycoprotein in transporting vesicles from KB-V1 multidrug resistant cells. Biochemistry 33: 8921-8929.
96. Liu JP (1996) Protein kinase C and its substrates. Mol Cell Endocrinol 116: 1-29.
97. Ma L, Marquardt D, Takemoto L and Center MS (1991) Analysis of P-glycoprotein phosphorylation in HL-60 cells isolated for resistance to vincristine. J Biol Chem 266: 5593-5599.
98. Ma L, Krishnamachary N and Center MS (1995) Phosphorylation of the multidrug resistance-associated protein gene encoded protein P190. Biochemistry 34: 3338-3343.
99. McCoy C, Smith DE and Cornwell MM (1995) 12-0-tetradecanoylphorbol-13-acetate activation of the MDR1 promoter is mediated by EGR1. Mol Cell Biol 15: 6100-6108.
100. Mellado W and Horwitz SB (1987) Phosphorylation of the multidrug resistance associated protein. Biochemistry 26: 6900-6904.
101. Meyers MB, Merluzzi VJ, Spengler BA and Biedler JL (1986) Epidermal growth factor receptor is increased in multidrug -resistant Chinese hamster and mouse tumour cells. Proc Natl Acad Sci USA 83: 5521-5525.
102. Meyers, MB, Shen WPV, Spengler BA, Ciccarone V, O'Brien JP, Donner DB, Furth ME and Biedler JL (1988) Increased epidermal growth factor receptor in multidrug-resistant human neuroblastoma cells. J Cell Biochem 38: 87-97.
103. Meyers, MB, Yu P and Mendelsohn, J (1993) Crosstalk between epidermal growth factor receptor and P-glycoprotein in actinomycin D-resistant Chinese hamster lung cells. Biochem Pharmacol 46: 1841-1848.
104. Mochly-Rosen D (1995) Localisation of protein kinases by anchoring proteins: a theme in signal transduction. Science 268: 247-251.
105. Nakamura S, Wakusawa S, Tajima K, Miyamoto KI, Hagiwara M and Hidaka H (1993) Effects of isoquinolinesulphonamide compounds on multidrug-resistant P388 cells. J Pharm Pharmacol 45: 268-271.
106. Nakamura S, Minamino T, Nomura M, Wakusawa S, Miyamoto KI and Hidaka H (1996) Inhibition of P-glycoprotein dependent multidrug resistance by an isoquinolinesulfonamide compound H-87 in rat ascites hepatoma AH66 cells. Biol Pharm Bull 19: 886-889.
107. Nakanishi H, Brewer KA and Exton JH (1993) Activation of the y isozyme of protein kinase C by phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 268: 13-16.
108. Newton AC (1995) Protein kinase C: structure, function and regulation. J Biol Chem 270: 28495-28498.
109. Newton AC (1996) Protein kinase C: ports of anchor in the cell. Curr Biol 6: 806-809.
110. Newton AC (1997) Regulation of protein kinase C. Curr Op Cell Biol 9: 161-167.
111. Nishizuka Y (1995) Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 9: 484-496.
112. O'Brian CA, Far D, Ward NE, Seud C and Fidler U (1989) Level of protein kinase activity correlates directly with resistance to Adriamycin in murine fibrosarcoma cells. FEBS Letts 246: 78-82.
113. O'Brian CA, Ward NE, Gravitt KR and Fan D (1994) The role of protein kinase C in multidrug resistance, In Goldstein LJ and Ozols RF (eds) Anticancer drug resistance: advances in molecular and clinical research (pp. 41-55) Kluwer Academic, London.
114. Ohkawa K, Hatano T, Isonishi S, Takada K, Joh K and Matsuda M (1994a) Characteristic changes in protein kinase C activity and isoforms in AH66 cells during the aquisition of multidrug resistance phenotype. Oncol Reports 1: 551-555.
115. Ohkawa K, Hatano T, Isonishi S, Takada K, Joh K and Matsuda M (1994b) Doxorubicin enhances transient expression of P-glycoprotein and modulates activity and isoform expression of protein kinase C in AH66 rat hepatoma cells. Int J Oncol 4: 655-659.
116. Olivier AR and Parker PJ (1992) Identification of multiple PKC isoforms in Swiss 3T3 cells-differential down regulation by phorbol ester. J Cell Physiol 152: 240-244.
117. Olivier AR and Parker PJ (1994) Bombesin, platelet-derived growth factor and diacylglycerol induce selective membrane association and downregulation of PKC isotypes in Swiss 3T3 cells. J Biol Chem 269: 2758-2763.
118. Orr GA, Han EKH, Browne PC, Nieves E, O'Connor BM, Yang CPH and Horwitz SB (1993) Identification of the major phosphorylation domain of murine mdr 1b P-glycoprotein. J Biol Chem 268: 25054-25062.
119. Osborn MT and Chambers TC (1996) Role of the stress-activated/c-Jun NH2-terminal protein kinase pathway in the cellular response to Adriamycin and other chemotherapeutic drugs. J Biol Chem 271: 30950-30955.
120. Palayoor ST, Stein JM and Hait WN (1987) Inhibition of protein kinase C by antineoplastic agents: implications for drug resistance. Biochem Biophys Res Commun 148: 718-725.
121. Parker PJ, Bosca L, Dekker L, Goode NT, Hajibagheri N and Hansra G (1995) Protein kinase C (PKC)-induced PKC degradation: a model for down-regulation. Biochem Soc Trans 23: 153-155.
122. Patterson KK, Beckman BS, Klotz DM, Mallia CM and Jeter JR (1996) Dexniguldipine hydrochoride, a protein kinase C-specific inhibitor, affects the cell cycle, differentiation, P-glycoprotein levels and nuclear protein phosphorylation in Friend erythroleukemia cells. J Cancer Res Clin Oncol 122: 465-475.
123. Pears C (1995) Structure and function of the protein kinase C gene family. J Biosci 20: 311-332.
124. Pearson BE and Kemp RB (1991) Protein kinase phosphorylation site sequences and consensus specificity motifs: tabulations. Methods in Enzymology: 200: 62-84.
125. Posada JA, McKeegan EN, Worthington KF, Morin NJ, Jaken S and Tritton TR (1989a) Human multidrug-resistant KB cells overexpress protein kinase C: involvement in drug resistance. Cancer Commun 1: 285-292.
126. Posada J, Vichi P and Tritton T (1989b) Protein kinase C in Adriamycin action and resistance in mouse sarcoma 180 cells. Cancer Res 49: 6634-6639.
127. Rabindran SK, Annable T, Brown EB, Collins KI and Green-berger LM (1995) Genistein modulates drug resistance in non-P-glycoprotein multidrug-resistant human colon carcinoma cells. Proc Am Assoc Cancer Res 36: 1928.
128. Rando RR and Kishi Y (1992) The structural basis of protein kinase C activation by diacylglycerols and tumour promoters, In Lester DS and Epand RM (eds) Protein kinase C (pp. 41-61) Ellis Horwood, Chichester.
129. Richon VM, Weich N, Leng L, Kiyokawa H, Ngo L, Rifkind RA and Marks PA (1991) Characteristics of erythroleukemia cells selected for vincristine resistance that have accelerated inducer-mediated differentiation. Proc Natl Acad Sci USA 88: 1666-1670.
130. Rohlff C, Ahmad S, Borellini F, Lei J and Glazer RI (1997) Modulation of transcription factor Spl by cAMP-dependent protein kinase. J Biol Chem 272: 21137-21141.
131. Rohlff C and Glazer RI (1995) regulation of multidrug resistance through the cAMP and EGF signalling pathways. Cell Signalling 7:431-443.
132. Roninson IB (1991) Molecular and cellular biology of multidrug resistance in tumour cells. Plenum Press, New York.
133. Sachs CW, Chambers TC, Blobe GC, Hannun YA and Fine RL (1995a) Phosphorylation of a synthetic P-glycoprotein peptide, PG-2, by calcium-dependent protein kinase C isoenzymes. Proc Am Assoc Cancer Res 36: 1987.
134. Sachs CW, Safa AR, Harrison SD and Fine RL (1995b) Partial inhibition of multidrug resistance by safingol is independent of modulation of P-glycoprotein substrate activities and correlated with inhibition of protein kinase C. J Biol Chem 270: 26639-26648.
135. Sampson KE, McCroskey MC and Abraham I (1993a) Identification of a 170 kDa membrane kinase with increased activity in KB-V1 multidrug-resistant cells. J Cell Biochem 52: 384-395.
136. Sampson KE, Wolf CL and Abraham I (1993b) Staurosporine reduces P-glycoprotein expression and modulates multidrug resistance. Cancer Letts 68: 7-14.
137. Sato W, Yusa K, Naito M and Tsuruo T (1990) Staurosporine, a potent inhibitor of C-kinase, enhances drug accumulation in multidrug-resistant cells. Biochem Biophys Res Commun 173: 1252-1257.
138. Sawai H, Okazaki T, Takeda Y, Tashima M, Sawada H, Okuma M, Kishi S, Umehara H and Domae N (1997) Ceramide-induced translocation of protein kinase C-S and -∈ to the cytosol. J Biol Chem 272: 2452-2458.
139. Scala S, Dickstein B, Regis J, Szallasi Z, Blumberg PM and Bates SE (1995a) Bryostatin 1 affects P-glycoprotein phosphorylation but not function in multidrug-resistant human breast cancer cells. Clin Cancer Res 1: 1581-1587.
140. Scala S, Budillon A, Zhan Z, Cho-Chung YS, Jefferson J, Tsokos M and Bates SE (1995b) Down-regulation of mdrl expression by 8-Cl-cAMP in multidrug resistant MCF-7 human breast cancer cells. J Clin Invest. 96: 1026-1034.
141. Schwartz GK, Arkin H, Holland JF and Ohnuma T (1991) Protein kinase C activity and multidrug resistance in MOLT3 human lymphoblastic leukemia cells resistant to trimetrexate. Cancer Res 51: 55-61.
142. Sha EC, Sha MC and Kaufmann SH (91996) Evaluation of 2,6-diamino-N-([-1(1-oxotridecyl)-2-piperidinyl] methyl) hexanamide (NPC 15437), a protein kinase C inhibitor, as a modulator of P-glycoprotein-mediated resistance in vitro. Invest. New Drugs 13:285-294.
143. Sharom FJ, Yu X, Chu JWK and Doige CA (1995) Characterisation of the ATPase activity of P-glycoprotein from multidrug-resistant Chinese hamster ovary cells. Biochem J 308: 381-390.
144. Simon SM and Schindler M (1994) Cell biological mechanisms of multidrug resistance in tumours. Proc Natl Acad Sci USA 91: 3497-3504.
145. Slapak CA, Rubin EH and Kufe DW (1993) Constitutive c-jun overexpression in doxorubicin and vincristine selected multidrug-resistant U937 cells. Proc Am Assoc Cancer Res 34: 1874.
146. Smith CD and Zilfou JT (1995) Circumvention of P-glycoprotein-mediated multiple drug resistance by phosphorylation modulators is independent of protein kinases. J Biol Chem 270: 28145-28152.
147. Srivastava RK, Srivastava AR and Cho-Chung YS (1996) Multidrug resistance in cancer. Int J Oncol 9: 879-884.
148. Stabel S (1994) Protein kinase C-an enzyme and its relatives. Sem Cancer Biol 5: 277-284.
149. Staats J, Marquardt D and Center MS (1990) Characterisation of a membrane-associated protein kinase of multidrug-resistant HL-60 cells which phosphorylates P-glycoprotein. J Biol Chem 265: 4084-4090.
150. Stein WD (1997) Kinetics of the multidrug transporter (P-glycoprotein) and its reversal. Physiol Rev 77: 545-590.
151. Stow M and Warr JR (1991) Amplification and expression of mdr genes and flanking sequences in verapamil-hypersensitive cell lines. Biochim Biophys Acta 1092: 7-14.
152. Stromskaya TP, Grigorian IA, Ossovskaya VS, Rybalkina EY, Chumakov PM and Kopnin BP (1995) Cell specific effects of ras oncogene and protein kinase C agonist TPA on P-glycoprotein function. FEES Lett 368: 373-376.
153. Takano H, Mickley L, Spengler B, Biedler JL and Fojo T (1991) Increased phosphorylation of topoisomerase II in etoposide-resistant mutants of human cancer KB cells. Cancer Res 51: 3951-3957.
154. Takeda Y Nishio K, Nitani H and Saijo N (1994) Reversal of multidrug resistance by tyrosine-kinase inhibitors in a non-P-glycoprotein-mediated multidrug resistance cell line. Int J Cancer 57: 229-239.
155. Utz I, Hofer S, Regenass U, Hilbe W, Thaler J, Grunicke H and Hofmann J (1994) The protein kinase C inhibitor CGP41251, a staurosporine derivative with antitumour activity, reverses multidrug resistance. Int J Cancer 57: 104-110.
156. van-Helvoort A, Smith A, Sprong H, Fritsche I, Schinkel AH, Borst P and van Meer G (1996) MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell 87: 507-517.
157. Vickers PJ, Dickson RB, Showmaker, R and Cowan KH (1988) A multidrug-resistant MCF-7 human breast cancer cell line which exhibits cross-resistance to antiestrogens and hormone-independent tumour growth in vivo. Mol Endocrinol 2: 886-892.
158. Volm M and Pommerenke EW (1995) Associated expression of protein kinase C with resistance to doxorubicin in human lung cancer. Anticancer Res 15: 463-466.
159. Wakusawa S, Inoko K, Miyamoto KI, Kajita S, Hasegawa T, Harimaya K and Koyama M (1993) Staurosporine derivatives reverse multidrug resistance without correlating with their protein kinase inhibitory activities. J Antibiotics 46: 353-355.
160. Ward NE and O'Brian CA (1991) Distinct pattern of phorbol ester-induced downregulation of PKC activity in Adriamycin-selected multidrug resistant and parental murine fibrosarcoma cells. Cancer Lett 58: 189-193.
161. Warr JR, Anderson M and Fergusson J (1988) Properties of verapamil-hypersensitive multidrug-resistant Chinese hamster ovary cells. Cancer Res 48: 4477-4483.
162. Welsh CJ, Yeh GC and Phang JM (1994) Increased phospholipase D activity in multidrug resistant breast cancer cells. Biochem Biophys Res Commun 202: 211-217.
163. Yang JM, Chin KV and Hait WN (1995) Involvement of phospholipase C in heat-shock induced phosphorylation of P-glycoprotein in multidrug resistant human breast cancer cells. Biochem Biophys Res Commun 210: 21-30.
164. Yang JM, Chin KV and Hait WN (1996) Interaction of P-glycoprotein with protein kinase C in human multidrug resistant carcinoma cells. Cancer Res 56: 3490-3494.
165. Yang JM, Sullivan, GF and Hiat WN (1997) Regulation of the function of P-glycoprotein by epidermal growth factor through phospholipase C. Biochem Pharmacol 53: 1597-1604.
166. Yokozaki H, Budillon A, Clair T, Kelley K, Cowan KH: Rohlff C, Glazer RI and Cho-Chung YS (1993) 8-chloroadenosine 3',5'-monophosphate as a novel modulator of multidrug resistance. Int J Oncol 3: 423-430.
167. Yu G, Ahmad S, Aquino A, Fairchild CR, Trepel JB, Ohno S, Suzuki K, Tsuruo T., Cowan KH and Glazer RI (1991) Transfection with protein kinase C-α confers increased multidrug resistance to MCF-7 cells expressing P-glycoprotein. Cancer Comm 3: 181-189.
168. Zuckier G and Tritton TR (1983) Adriamycin causes upregulation of epidermal growth factor receptors in actively growing cells. Exp Cell Res 148: 155-161.
169. Zwelling LA, Hinds M, Chan E, Altschuler J, Mayes J and Zipf TF (1990) Phorbol ester effects on topoisomerase II activity and gene expresion in HL-60 human leukaemia cells with different proclivities toward monocytoid differentiation. Cancer Res 50: 7116-7122.